LifeMD (LFMD) Common Equity (2012 - 2026)

LifeMD (LFMD) has reported Common Equity for 15 consecutive years, with $100.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 2458.63% year-over-year to $100.0 million; the trailing twelve-month figure through Jun 2026 stood at $100.0 million (up 2458.63% YoY), and the FY2025 full-year result was $100.0 million, up 1200.93% from the prior year.
• Common Equity was little changed at $100.0 million in Q2 2026 per LFMD's latest filing, from $100.0 million in the prior quarter.
• Across five years, Common Equity topped out at $100.0 million in Q4 2025 and bottomed at -$15.2 million in Q2 2023.
• Historically, Common Equity has averaged $13.7 million across 5 years, with a median of -$1.6 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Common Equity plunged 714.94% in 2023, then surged 2458.63% in 2026.
• Over 5 years, Common Equity stood at -$11.9 million in 2022, then surged by 135.29% to $4.2 million in 2023, then plunged by 316.83% to -$9.1 million in 2024, then jumped by 1200.93% to $100.0 million in 2025, then changed by 0.0% to $100.0 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $100.0 million, $100.0 million, and $100.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.